Drugs for Endometriosis of Ovary (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show all 12)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Anastrozole |
Approved, Investigational |
Phase 4 |
|
120511-73-1 |
2187 |
Synonyms:
.alpha.,alpha.,.alpha.',.alpha.'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
1,3-benzenediacetonitrile, a, a, a', a'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)
120511-73-1
2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)
2,2'-(5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)
2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)
2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)
2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile
a,a,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
AC1L1D49
AC-4234
alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
alpha,alpha,Alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
anastrazole
Anastrazole
Anastrole
Anastrozol
anastrozole
Anastrozole
Anastrozole (JAN/USAN/INN)
Anastrozole [USAN:INN:BAN]
Arimidex
Arimidex (TN)
Arimidex (Zeneca)
Arimidex, Anastrozole
Asiolex
Astra brand of anastrozole
Astra brand OF anastrozole
AstraZeneca brand of anastrozole
AstraZeneca brand OF anastrozole
C08159
C090450
C17H19N5
|
CHEBI:2704
CHEMBL1399
CID2187
CPD000466301
D00960
DB01217
HMS2052M11
HMS2089N10
HSDB 7462
I06-0021
ICI D1033
ICI-D 1033
ICI-D1033
LS-29563
MLS000759396
MLS001424217
MolPort-005-933-078
NCGC00164619-01
NSC719344
S1188_Selleck
SAM001246525
SBB066057
SMR000466301
UNII-2Z07MYW1AZ
ZD 1033
ZD1033
ZD-1033
Zeneca brand of anastrozole
Zeneca brand OF anastrozole
Zeneca ZD 1033
ZINC00000941
α,α,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
α,α,α',α'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile
|
|
2 |
|
Goserelin |
Approved |
Phase 4 |
|
65807-02-5 |
5311128 47725 |
Synonyms:
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
AC1NSK1T
Acetate, goserelin
CID5311128
goserelin
Goserelin
Goserelin acetate
Goserelina
|
HMS2089D16
HS-2015
ICI 118
ICI-118630
ICI-118630Zoladex
MolPort-006-823-831
ZD-9393
Zoladex
|
|
3 |
|
Antineoplastic Agents, Hormonal |
|
Phase 4 |
|
|
|
4 |
|
Estrogen Antagonists |
|
Phase 4 |
|
|
|
5 |
|
Aromatase Inhibitors |
|
Phase 4 |
|
|
|
6 |
|
Estrogens |
|
Phase 4 |
|
|
|
7 |
|
Estrogen Receptor Antagonists |
|
Phase 4 |
|
|
|
8 |
|
Medroxyprogesterone acetate |
Approved, Investigational |
Phase 2 |
|
71-58-9 |
|
Synonyms:
(6α)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
17-Acetoxy-6α-methylprogesterone
17α-hydroxy-6α-methylprogesterone acetate
6-alpha-Methyl-17-alpha-acetoxyprogesterone
6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate
6α-Methyl-17-acetoxy progesterone
6α-Methyl-17α-hydroxyprogesterone acetate
|
6α-Methyl-4-pregnene-3,20-dion-17α-ol acetate
Medroxyacetate progesterone
Medroxyprogesterone 17-acetate
Methylacetoxyprogesterone
Metigestrona
MPA
|
|
9 |
|
Medroxyprogesterone |
|
Phase 2 |
|
520-85-4 |
10631 |
Synonyms:
(6alpha)-17-hydroxy-6-methylpregn-4-ene-3,20-dione
(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-17-hydroxy-6,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
17 alpha Hydroxy 6 alpha methylprogesterone
17 alpha Hydroxy 6 alpha Methylprogesterone
17 alpha-Hydroxy-6 alpha-methylprogesterone
17 alpha-Hydroxy-6 alpha-Methylprogesterone
17.alpha.-Hydroxy-6.alpha.-methylprogesterone
17a-Hydroxy-6a-methylprogesterone
17alpha-Hydroxy-6alpha-methyl-4-pregnene-3,20-dione
17alpha-Hydroxy-6alpha-methylprogesterone
17-Hydroxy-6.alpha.-methylprogesterone
17-Hydroxy-6alpha-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6alpha-methylprogesterone
17-Hydroxy-6a-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6a-methylprogesterone
17-Hydroxy-6α-methyl-pregn-4-ene-3,20-dione
17-Hydroxy-6α-methylprogesterone
17α-hydroxy-6α-methylprogesterone
4-08-00-02211 (Beilstein Handbook Reference)
46411_FLUKA
46411_RIEDEL
520-85-4
6.alpha.-Methyl-17.alpha.-hydroxyprogesterone
6alpha-Methyl-17alpha-hydroxyprogesterone
6-alpha-Methyl-17-alpha-hydroxyprogesterone
6alpha-Methyl-4-pregnen-17alpha-ol-3,20-dione
6alpha-Methyl-5-pregnen-17alpha-ol-3,20-dione
6a-Methyl-17a-hydroxyprogesterone
6a-Methyl-4-pregnen-17a-ol-3,20-dione
6-Dihydromegestrol
6α-methyl-17α-hydroxyprogesterone
6α-methyl-4-pregnen-17α-ol-3,20-dione
AC-14528
AC1L1VM7
Adgyn medro
Adgyn Medro
Aragest
Aragest 5
Asconale
BRN 2510965
C07119
CBP-1011
CHEBI:6715
CHEMBL1390
CID10631
Clinofem
Clinovir
Colirest
CPD000058769
Cycrin
D008525
D08166
DB00603
Depo-Clinovir
Depo-Prodasone
Depo-Progestin
Depo-Promone
depo-Provera
depo-Subq provera 104
Depot-Medroxyprogesterone acetate
DMPA
EINECS 208-298-6
Farlutal
Farlutal inyectable
Farlutal inyectable (TN)
Farlutin
Gestapuran
g-Farlutal
G-Farlutal
|
Hematrol
HMS2052A13
HSDB 3114
Hydroxymethylprogesterone
Hysron
Indivina
LMST02030176
LS-118713
Lunelle
Lutopolar
Lutoral
M6013_SIGMA
MAP
Med-Pro
Medroprogesterone Acetate
Medrossiprogesterone
Medrossiprogesterone [Dcit]
Medrossiprogesterone [DCIT]
Medroxiprogesterona
Medroxiprogesterona [INN-Spanish]
Medroxiprogesteronum
Medroxyprogesteron
Medroxyprogesteron acetate
medroxyprogesterone
Medroxyprogesterone (INN)
Medroxyprogesterone [INN:BAN]
Medroxyprogesterone acetate
Medroxyprogesterone strakan brand
Medroxyprogesterone Strakan Brand
Medroxyprogesteronum
Medroxyprogesteronum [INN-Latin]
Meprate
Methylhydroxyprogesterone
Metigestrona
MLS000069571
MLS001076098
MolPort-005-934-866
MPA Gyn 5
Nadigest
NCGC00023064-04
Nidaxin
Novo-Medrone
NSC 27408
NSC27408
Oragest
Perlutex
Perlutex Leo
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6alpha)- (9CI)
Pregn-4-ene-3,20-dione, 17-hydroxy-6-methyl-, (6-alpha)- (9CI)
Prodasone
Progestalfa
Progevera
Provera
Proverone
Ralovera
Repromap
Repromix
SAM001246906
Sirprogen
SMR000058769
Sodelut G
ST082267
Strakan brand OF medroxyprogesterone
Strakan Brand of Medroxyprogesterone
U 8840
UNII-HSU1C9YRES
Veramix
ZINC05763835
|
|
10 |
|
Hormones |
|
|
|
|
|
11 |
|
Hormone Antagonists |
|
|
|
|
|
12 |
|
Hemostatics |
|
|
|
|
|
Interventional clinical trials:
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Use of Arimidex and Zoladex as Pretreatment to IVF in Women With Ovarian Endometriosis |
Completed |
NCT00286351 |
Phase 4 |
Combined treatment with Arimidex and Zoladex before IVF |
2 |
A Phase IIa Efficacy and Safety Study of PGL5001 Versus Placebo Administered for up to 5 Months With Concomitant Administration of Depot Medroxyprogesterone Acetate for the Treatment of Peritoneal and/or Ovarian Endometriosis With an Inflammatory Component. |
Completed |
NCT01630252 |
Phase 2 |
PGL5001;Placebo;PGL5001;Placebo;PGL5001 |
3 |
Optimum Menstrual Cycle Time for Endometrioma Excision |
Unknown status |
NCT03484546 |
|
|
4 |
"Identification, Characterization and Isolation of Somatic Stem Cells in Human Endometrium of Women With Endometriosis" |
Unknown status |
NCT01412138 |
|
|
5 |
Impact on Ovarian Reserve According to the Type of Ovarian Endometrioma Excision: Laser Versus Conventional Cystectomy |
Completed |
NCT03826355 |
|
|
6 |
Methylation of cfDNA in Diagnosis and Differential Diagnosis of Ovarian Endometriosis |
Recruiting |
NCT04220710 |
|
|
7 |
Ovarian Function After Use of Various Hemostatic Techniques During Treatment for Endometrioma: A Randomized Control Trial |
Recruiting |
NCT03430609 |
|
|
8 |
Perinatal Consequences of Endometriosis: Multicenter Prospective Comparative Study |
Active, not recruiting |
NCT02498691 |
|
|
9 |
Study of the Relationship Between Oxidative Stress Gene Polymorphism and Individual Variation of Ovarian Reserve Function in Patients With Ovarian Endometrioma |
Not yet recruiting |
NCT03682341 |
|
|
|